Identification and Optimization of a Minor Allele-Specific Small Interfering RNA to Prevent PNPLA3 I148M-Driven Nonalcoholic Fatty Liver Disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification and Optimization of a Minor Allele-Specific Small Interfering RNA to Prevent PNPLA3 I148M-Driven Nonalcoholic Fatty Liver Disease
Authors
Keywords
-
Journal
Nucleic Acid Therapeutics
Volume -, Issue -, Pages -
Publisher
Mary Ann Liebert Inc
Online
2021-07-24
DOI
10.1089/nat.2021.0026
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
- (2020) Stefano Romeo et al. Cell Metabolism
- Givosiran: First Approval
- (2020) Lesley J. Scott DRUGS
- Effect of the patatin‐like phospholipase domain containing 3 gene ( PNPLA3 ) I148M polymorphism on the risk and severity of nonalcoholic fatty liver disease and metabolic syndromes: A meta‐analysis of paediatric and adolescent individuals
- (2020) Jiaying Li et al. Pediatric Obesity
- A structural variation reference for medical and population genetics
- (2020) Ryan L. Collins et al. NATURE
- Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis
- (2020) Shan Tang et al. BMC Medical Genetics
- Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program
- (2020) Marina Serper et al. PLoS One
- Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria
- (2019) Eliane Sardh et al. NEW ENGLAND JOURNAL OF MEDICINE
- The current state and future directions of RNAi-based therapeutics
- (2019) Ryan L. Setten et al. NATURE REVIEWS DRUG DISCOVERY
- Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity
- (2019) Guangrong Dai et al. MEDICINE
- Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis
- (2019) Soumik BasuRay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
- (2019) Daniel Lindén et al. Molecular Metabolism
- Allele-specific silencing as treatment for gene duplication disorders: proof-of-principle in autosomal dominant leukodystrophy
- (2019) Elisa Giorgio et al. BRAIN
- A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system
- (2019) Julia F. Alterman et al. NATURE BIOTECHNOLOGY
- Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates
- (2018) Donald J. Foster et al. MOLECULAR THERAPY
- Noninvasive biomarkers in NAFLD and NASH — current progress and future promise
- (2018) Vincent Wai-Sun Wong et al. Nature Reviews Gastroenterology & Hepatology
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patisiran: First Global Approval
- (2018) Sheridan M. Hoy DRUGS
- Gene-silencing technology gets first drug approval after 20-year wait
- (2018) Heidi Ledford NATURE
- The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation
- (2017) Soumik BasuRay et al. HEPATOLOGY
- The chemical evolution of oligonucleotide therapies of clinical utility
- (2017) Anastasia Khvorova et al. NATURE BIOTECHNOLOGY
- A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
- (2017) Kevin Fitzgerald et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates
- (2017) Jayaprakash K. Nair et al. NUCLEIC ACIDS RESEARCH
- Impact of Oligonucleotide Structure, Chemistry, and Delivery Method on In Vitro Cytotoxicity
- (2017) Maja M. Janas et al. Nucleic Acid Therapeutics
- TIMP-1 is upregulated, but not essential in hepatic fibrogenesis and carcinogenesis in mice
- (2017) Nina D. Thiele et al. Scientific Reports
- Development of antibody-siRNA conjugate targeted to cardiac and skeletal muscles
- (2016) Tsukasa Sugo et al. JOURNAL OF CONTROLLED RELEASE
- PNPLA3 gene in liver diseases
- (2016) Eric Trépo et al. JOURNAL OF HEPATOLOGY
- Exposure to siRNA-GalNAc Conjugates in Systems of the Standard Test Battery for Genotoxicity
- (2016) Maja M. Janas et al. Nucleic Acid Therapeutics
- Hepatocyte-Specific Delivery of siRNAs Conjugated to Novel Non-nucleosidic TrivalentN-Acetylgalactosamine Elicits Robust Gene Silencing in Vivo
- (2015) Kallanthottathil G. Rajeev et al. CHEMBIOCHEM
- Therapy for Dominant Inherited Diseases by Allele-Specific RNA Interference: Successes and Pitfalls
- (2015) Delphine Trochet et al. CURRENT GENE THERAPY
- Genetic Variants in the SAMM50 Gene Create Susceptibility to Nonalcoholic Fatty Liver Disease in a Chinese Han Population
- (2015) Lizhen Chen et al. Hepatitis Monthly
- Association Between Patatin-Like Phospholipase Domain Containing 3 Gene (PNPLA3) Polymorphisms and Nonalcoholic Fatty Liver Disease: A HuGE Review and Meta-Analysis
- (2015) Renfan Xu et al. Scientific Reports
- The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis
- (2014) Amit G Singal et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Pnpla3I148Mknockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis
- (2014) Eriks Smagris et al. HEPATOLOGY
- The rs738409 (I148M) variant of thePNPLA3gene and cirrhosis: a meta-analysis
- (2014) Jian-Hua Shen et al. JOURNAL OF LIPID RESEARCH
- Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
- (2014) Jayaprakash K. Nair et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A novel measurement of allele discrimination for assessment of allele-specific silencing by RNA interference
- (2014) Masaki Takahashi et al. MOLECULAR BIOLOGY REPORTS
- PNPLA3/adiponutrin functions in lipid droplet formation
- (2013) Zeina Chamoun et al. BIOLOGY OF THE CELL
- Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan
- (2013) Takuya Kitamoto et al. HUMAN GENETICS
- Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis
- (2012) John Zhong Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Unique Gene-Silencing and Structural Properties of 2′-Fluoro-Modified siRNAs
- (2011) Muthiah Manoharan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease
- (2011) Silvia Sookoian et al. HEPATOLOGY
- Diet-induced obesity affects expression of adiponutrin/PNPLA3 and adipose triglyceride lipase, two members of the same family
- (2011) P Oliver et al. INTERNATIONAL JOURNAL OF OBESITY
- Expression and Characterization of a PNPLA3 Protein Isoform (I148M) Associated with Nonalcoholic Fatty Liver Disease
- (2011) Yongcheng Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Development of Allele-Specific Therapeutic siRNA in Meesmann Epithelial Corneal Dystrophy
- (2011) Haihui Liao et al. PLoS One
- Regulation of the promoter region of the human adiponutrin/PNPLA3 gene by glucose and insulin
- (2010) Sharleen M. Rae-Whitcombe et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease
- (2010) Weiqin Chen et al. HEPATOLOGY
- The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life
- (2010) Stefano Romeo et al. JOURNAL OF HEPATOLOGY
- Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes
- (2010) Céline Dubuquoy et al. JOURNAL OF HEPATOLOGY
- Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome
- (2010) Mahesh K. Basantani et al. JOURNAL OF LIPID RESEARCH
- A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis
- (2010) Zobair M. Younossi et al. OBESITY SURGERY
- A feed-forward loop amplifies nutritional regulation of PNPLA3
- (2010) Yongcheng Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis
- (2009) Shaoqing He et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Variant in PNPLA3 is associated with alcoholic liver disease
- (2009) Chao Tian et al. NATURE GENETICS
- Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent
- (2008) Laura H. Tetri et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Chemically modified siRNA: tools and applications
- (2008) J WATTS et al. DRUG DISCOVERY TODAY
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More